Johnson and Johnson asked to cut down price of new TB drug
Medicines Sans Frontiers (MSF) has called upon US drug maker c (J&J) to cut down the price of its new tuberculosis drug Bedaquiline, as the high price of the drug…
Mumbai: PIL against antibiotics’ sale without prescription
MUMBAI: A lawyer has filed a PIL in the Bombay HC against the Union and state governments, Central Drugs Standard Control Organization (CDSCO) and drug regulator to prevent the rampant…
Pharma co buys Rs 350-cr plot
One of the biggest pharmaceutical companies in the country is moving its corporate headquarters. And, in doing so, it has given a fillip to the city’s realty market by buying…
Merck KGaA says might strike partnership deal this year
MUNICH: German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely…
AbbVie CFO Chase stepping down, to retire by mid-year 2019
AbbVie Inc said on Friday that Chief Financial Officer William Chase is retiring in mid-2019 and named its controller, Robert Michael, his immediate successor as CFO. Michael, 48, will report…
Pharmacist who wouldn’t fill miscarriage drug is out
PETOSKEY, Mich.: A Michigan pharmacist accused of refusing to fill a prescription to help a woman complete a miscarriage no longer works for the Meijer retail chain. Meijer spokeswoman Christina…
Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.…
FDA snubs Novartis bid to repurpose inflammation drug for heart attacks
By John Miller ZURICH: The U.S. Food and Drug Administration has rejected Novartis’s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group…
Uttar Pradesh government planned to open Six Pharma Parks
Six Pharma Parks has been planned to set-up in the Uttar Pradesh state as the state has been received an investment commitment of about Rs 5,000-6,000 crore from domestic and…
Piramal weighs $1bn contract pharma sale
Billionaire Ajay Piramal is considering a sale of his contract pharmaceutical operations, which could fetch around $1 billion, people with knowledge of the matter said. The tycoon’s Piramal Enterprises is…
